BRIEF-AstraZeneca to collaborate with Harvard Stem Cell Institute in diabetes

* To collaborate with Harvard Stem Cell Institute in diabetesFurther company coverage: (Reporting By Ben Hirschler)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.